Phase II study of hypofractionated image-guided radiotherapy for localized prostate cancer: Outcomes of 55Â Gy in 16 fractions at 3.4Â Gy per fraction

Hypofractionated radiotherapy is clinically feasible and more convenient than conventional schedules for patients with localized prostate cancer. Phase 3 multicenter studies are on-going (NCT00126165).